Wegovy vs Zepbound: which one should I ask for and where do I get either online?

Short answer

• Both Wegovy (semaglutide, Novo Nordisk) and Zepbound (tirzepatide, Eli Lilly) are prescription weekly injectable drugs FDA‑approved for chronic weight management. Which to ask for depends on your health history and goals.
• In general, tirzepatide (Zepbound) has produced somewhat larger average weight loss in clinical trials than semaglutide (Wegovy), but both work well and have similar GI side effects. Talk with a clinician to pick the right one for you.

Quick comparison — plain-language points

• Mechanism: Wegovy = semaglutide (GLP‑1 agonist). Zepbound = tirzepatide (dual GIP + GLP‑1). Both reduce appetite and slow gastric emptying.
• Efficacy: Clinical trials show larger average weight loss with tirzepatide than semaglutide, though individual response varies.
• Side effects: Both commonly cause nausea, vomiting, constipation/diarrhea; tirzepatide may have slightly higher rates of GI effects in some studies. Rare but serious risks include pancreatitis and gallbladder problems; both carry a rodent thyroid C‑cell tumor warning (avoid if personal/family history of medullary thyroid carcinoma or MEN2).
• Dosing/form: Both are once‑weekly subcutaneous injections with gradual dose escalation supervised by a prescriber.
• Other medical considerations: If you have type 2 diabetes, heart disease, kidney disease, pregnancy/breastfeeding plans, or other major conditions, that can change the preferred choice.

Which should you ask for?

• Ask your clinician to help decide. Useful rules of thumb:
  • If you need stronger glucose lowering in addition to weight loss, tirzepatide (Zepbound/Mounjaro) is often favored because it has greater effects on blood sugar.
  • If you have tolerated semaglutide before or prefer its safety/experience profile, Wegovy remains a very effective option.
  • If you have personal/family history of MEN2 or medullary thyroid cancer, neither is appropriate.
• Don’t ask for a specific drug as a demand; instead ask your clinician: “Given my medical history and goals, would you recommend Wegovy (semaglutide) or Zepbound (tirzepatide)? Why?”

Where to get them online

1. Start with a licensed prescriber

   • You need a prescription from your PCP, endocrinologist, obesity medicine specialist, or an online telehealth clinician. Don’t obtain injectables without legitimate medical evaluation and supervision.

2. Manufacturer resources

   • Wegovy (Novo Nordisk): wegovy.com — the site has patient support info and assistance programs.
   • Zepbound (Eli Lilly): zepbound.com — includes savings/copay information and FAQs. These pages also explain how to enroll in manufacturer savings and patient assistance programs.

3. Fill the prescription at reputable pharmacies / specialty pharmacies

   • Local chains (CVS, Walgreens, Walmart) and most large mail‑order/specialty pharmacies will fill these injectables when you present a valid prescription.
   • If your plan uses a specialty mail pharmacy, your insurer (or pharmacy benefit manager such as Express Scripts/OptumRx/CVS Caremark) will give instructions for ordering.

4. Telehealth services that commonly evaluate and prescribe GLP‑1/Tirzepatide under medical supervision

   • Examples of widely used telehealth clinics that offer weight‑management programs and can prescribe when appropriate: Hims & Hers, Ro, PlushCare. (Availability and prescribing practices vary by company and state.)
   • Make sure the service includes a medical evaluation, lab review if needed, ongoing follow‑up, and a way to contact a clinician about side effects.

5. Price-shopping and coupons

   • Use GoodRx or SingleCare to compare prices and coupons for the pharmacy fill.
   • Check manufacturer copay cards (if eligible) and insurer prior‑authorization requirements before ordering.

Safety and next steps (important)

• I’m not a doctor. Before asking for either drug, have a medical visit to review:
  • Current medications, diabetes status, pregnancy/breastfeeding plans, personal/family history of medullary thyroid carcinoma or MEN2, pancreatitis, gallbladder disease, severe kidney or liver disease.
• Ask about monitoring (weight, blood sugar if diabetic, labs), the dose escalation schedule, and how to manage GI side effects.
• If you want, tell me your age, major medical conditions, and current meds and I can help prepare a short script/summary you can bring to your clinician to discuss Wegovy vs Zepbound.